Full Projects
1. I CARE (Immunotherapy Cutaneous Adverse events REsearch)
PIs: Bao Vuong, PhD; Francesca Gany, MD, MS; Neil Shah, MBBS; Alina Markova, MD
Project Dates: 9/2024 – Present
Objectives:
-
Further identify biological factors associated with immune-related cutaneous adverse event development.
-
Identify associations between social influences of health and allostatic load with immune-related cutaneous adverse events and immune checkpoint inhibitor outcomes.
-
Conduct a randomized controlled trial to determine the impact of a side-effects navigation program compared with enhanced usual and customary care.
2. Structural, chemical, and cellular probing of a new anticancer target: HIF-coactivator complexes
PIs: Kevin Gardner, PhD; Derek Tan, PhD
Project Dates: 9/2024 – Present
Objectives:
-
Determine the structural basis of HIF/coiled-coil coactivator interactions.
-
Use structural information to develop small-molecule HIF/CCC inhibitors.
-
Evaluate the cellular importance of HIF/coactivator interactions and the effects of the inhibitors on HIF-driven gene expression.
Pilot Projects
3. Characterization of the role of RNA methylation in brain cancer progression
PIs: Jennifer Malin, PhD; Eric Lai, PhD
Project Dates: 9/2026 – Present
Objectives: To characterize how m6A RNA methylation regulators contribute to brain cancer progression and identify m6A-modified transcripts that may drive tumor growth in Drosophila models of glioma and medulloblastoma.
4. GLOW (Get the LOwdown on alcohol and Wellness): A Pilot Randomized Controlled Trial
PIs: Wenhua Lu, PhD; Florence Lui, PhD
Project Dates: 9/2026 – Present
Objectives: To pilot a genetically and linguistically tailored brief alcohol literacy intervention to increase awareness of alcohol as a cancer risk factor and reduce harmful alcohol use; assess feasibility, acceptability, recruitment, retention, adherence, and preliminary changes in alcohol-related cancer knowledge and self-reported alcohol use.
5. At the Intersection of Tumor, Immunity, and Muscle: Defining Early Molecular Events in Cancer Cachexia
PIs: Shuba Govind, PhD; Mary Baylies, PhD
Project Dates: 1/2027- Present
Objective: To identify the early molecular events that cause skeletal muscle wasting in cancer cachexia, using Drosophila models to study how tumor-derived signals and inflammation trigger muscle atrophy.
6. Multi Cancer Early Detection in Under Resourced Populations
PIs: Ronald Koder, PhD; Daniel Heller, PhD
Project Dates: 3/2026 – 2/2027
Objective:
-
Develop an AI-enabled, low-cost liquid biopsy platform using carbon nanotube optical nanosensors and machine learning to detect cancer from blood samples, initially focusing on non-small cell lung cancer with future expansion to multiple cancers.
Pre-pilot Projects
1. Developing Asian GLOW (Get the LOwdown on alcohol and Wellness)
PIs: Wenhua Lu, PhD; Florence Lui, PhD
Project Dates: 9/2026 – 2/2027
Objectives: To develop an linguistically tailored, brief alcohol intervention adapted from an evidence-based alcohol literacy intervention to improve awareness of alcohol as a cancer risk factor.
Previously Funded Projects
Pilot Projects
1. AI HEALS (HEalth Advances through Language Solutions)?
PIs: Jie Wei, PhD; Carlos Riobó, PhD; Francesca Gany, MD, MS; Javier González, MFA
Project Dates: 9/2024 – 8/2026
Objectives:
-
Compare the accuracy of three interpreting modalities: person-rendered consecutive interpreting, person-rendered remote simultaneous interpreting, and AI simultaneous medical interpreting.
-
Compare the efficiency of the interpreting modalities using audio recordings and the IHCD Efficiency Tool.
-
Assess the acceptability of AI simultaneous medical interpreting among patients and healthcare-system stakeholders.
2. Comprehensive characterization of ancestry-associated immune features and response to immunotherapy
PIs: Sanna Goyert, PhD; Christopher Fong, PhD; Jian Carrot-Zhang, PhD
Project Dates: 9/2024 – 8/2026
Objectives:
-
Identify genetic variability and environmental factors associated with somatic mutations.
-
Investigate the relationship between smoking exposure and response to immunotherapy in patients.
3. Digital Health Navigators for Spanish-Speaking Cancer Patients
PIs: Carlos Riobó, PhD; Lisa Diamond, MD, MPH
Project Dates: 1/2024 – 8/2025
Objectives:
-
Pilot the Digital Health Navigator intervention with 30 Spanish-speaking patients at the MSK Ralph Lauren Center and assess patient portal use and eHealth competence.
-
Evaluate the intervention using the RE-AIM QuEST framework through surveys, focus groups, and leadership interviews.
-
Assess DHN feedback on training, program recommendations, and career planning to inform a future randomized controlled trial.
Pre-Pilots
1. Adapting Single-Session Consultation for Cancer (SSC-C) to alleviate distress among breast cancer patients receiving immunotherapy
PIs: Adriana Espinosa, PhD; Devika Jutagir, PhD
Project Dates: 3/2025 – 12/2026
Objectives:
-
Adapt Single-Session Consultation into SSC for Cancer through focus groups with 32 stakeholders.
-
Pre-pilot SSC-C with 20 breast cancer patients waitlisted for outpatient psychotherapy.
-
Assess self-efficacy, distress, and intervention feasibility, with the goal of improving self-efficacy and reducing distress.
2. Bridging Gaps in Cancer Care: A mixed-methods approach to investigating cancer care impediments, facilitators, and outcomes
PIs: Larry Au, PhD; Joshua Budhu, MD
Project Dates: 3/2025 – 12/2026
Objectives:
-
Leverage existing databases and public resources to study emergency insurance coverage in New York State.
-
Conduct 30 interviews with Cancer Center Directors and clinicians to assess impediments, facilitators, and outcomes.
-
Combine quantitative database analysis with qualitative data collection from care providers.